Investor Relations

Stock Quote (NASDAQ: PODD)

- 0.24
Day High:
Day Low:
4:00 PM ET on Jul 2, 2015
Delayed ~20 min. By eSignal.
Stock price graph

Corporate Profile

Insulet Corporation is an innovative medical device company based in Billerica, Massachusetts. It was founded in 2000 with the mission of improving the lives of people with diabetes. Specifically, through its revolutionary OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy.

Studies have demonstrated the advantages of insulin pump therapy over multiple daily insulin injections (MDI); these advantages include better glycemic control, fewer hypoglycemic events, reduced glycemic variability1 and improved quality of life2. Despite these benefits, most people still choose MDI therapy largely due to the complexity, cost and inconvenience of conventional..More ▼

View all »   RSSRecent Releases

Jun 30, 2015
Insulet Announces Organizational Changes

Jun 5, 2015
Insulet Corporation Celebrates a Decade of Innovation at the American Diabetes Association's 75th Scientific Sessions

View all »Events & Presentations

Apr 30, 2015
Q1 2015 Insulet Corporation Earnings Conf Call
Webcast Listen to webcast
PDF Historical Revenue by Business Line   58.9 KB   Add to Briefcase

Mar 4, 2015
Cowen and Company 35th Annual Health Care Conference
Webcast Listen to webcast